Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mesoblast Ltd (DE:LWBA)
FRANKFURT:LWBA
Mesoblast (LWBA) Stock Price & Analysis
0 Followers
LWBA Stock Chart & Stats
Day’s Range€0.94 - €0.94
52-Week Range― - ―
Previous Close€0.94
Volume0.00
Average Volume (3M)N/A
Market Cap
$177.23M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next Earnings
Feb 28, 2024EPS Estimate
-€0.16Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Mesoblast News
Options Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
0.00%
Mutual Funds
0.02% Other Institutional Investors
99.98% Public Companies and
Individual Investors
LWBA FAQ
What was Mesoblast Ltd’s price range in the past 12 months?
Currently, no data Available
What is Mesoblast Ltd’s market cap?
Currently, no data Available
When is Mesoblast Ltd’s upcoming earnings report date?
Mesoblast Ltd’s upcoming earnings report date is Feb 28, 2024 which is 57 days ago.
How were Mesoblast Ltd’s earnings last quarter?
Mesoblast Ltd released its earnings results on Nov 22, 2023. The company reported -€0.113 earnings per share for the quarter, the consensus estimate of -€0.113 by €0.
Is Mesoblast Ltd overvalued?
According to Wall Street analysts Mesoblast Ltd’s price is currently Overvalued.
Does Mesoblast Ltd pay dividends?
Mesoblast Ltd does not currently pay dividends.
What is Mesoblast Ltd’s EPS estimate?
Mesoblast Ltd’s EPS estimate is -€0.16.
How many shares outstanding does Mesoblast Ltd have?
Currently, no data Available
What happened to Mesoblast Ltd’s price movement after its last earnings report?
Mesoblast Ltd reported an EPS of -€0.113 in its last earnings report, expectations of -€0.113. Following the earnings report the stock price went up 4.386%.
Which hedge fund is a major shareholder of Mesoblast Ltd?
Currently, no hedge funds are holding shares in DE:LWBA
---
Mesoblast Stock Smart Score
Company Description
Mesoblast Ltd
Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target the cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. The company was founded by Itescu Silviu on June 8, 2004 and is headquartered in Melbourne, Australia.
---
LWBA Earnings Call
Q4 2023
0:00 / 0:00
---
LWBA Stock 12 Months Forecast
Average Price Target
―Technical Analysis
Mesoblast
―
BioMarin Pharmaceutical
―
Sarepta Therapeutics
―
Bluebird Bio
―
Crispr Therapeutics AG
―
Best Analysts Covering LWBA
1 Year
1 Year Success Rate
1/5 ratings generated profit
1 Year Average Return
-32.82%
reiterated a buy rating 8 months ago
Copying Louise Chen's trades and holding each position for 1 Year would result in 20.00% of your transactions generating a profit, with an average return of -32.82% per trade.
---